PARK CITY, Utah--(BUSINESS WIRE)--BlueWind Medical, Ltd., a leader in implantable Tibial Neuromodulation (iTNM) and developer of the Revi® System, a patient-centric solution for urge urinary ...

BAY COUNTY, Fla. (WMBB) – Bay County’s Advanced Urology Institute is being recognized as a center of excellence for treating ...

Dear Dr. Roach: My daughter, who is 50, recently went to a urologist for bladder retention issues. She had several tests performed. My daughter’s doctor told her that the diagnosis is “overactive ...

Rechargeable technology is finally available to patients struggling with overactive bladder, fecal incontinence, and urinary retention. While rechargeable implants are already the norm for spinal cord ...

This x-ray of the pelvis shows an electronic nerve-stimulating device in the right iliac fossa. Over 10 months, complete continence was achieved by approximately half of implanted patients. Real-world ...

(RTTNews) - Medtronic plc (MDT) announced FDA approval to proceed with an investigational device exemption trial to evaluate its implantable tibial neuromodulation device — a therapy designed to ...

A 41-year-old nurse from Severance shopping for a solution to her overactive bladder symptoms found a way to regain full control thanks to an innovative procedure. Sarah Avrech said goodbye to a life ...

Tibial nerve stimulation (TNS) for overactive bladder (OAB) is a treatment that uses electrical signals to help control bladder contractions. It can reduce the number of times a person feels the urge ...

DOWNERS GROVE, IL / ACCESS Newswire / December 2, 2025 / Dr. Sarah Martin, a women's urology specialist at Duly Health and Care's Chicagoland medical group, DuPage Medical Group, Ltd., this month ...

In 2020, hot on the heels of Axonics Modulation Technologies’ FDA approval for a rechargeable neuromodulation implant to treat urinary and bowel dysfunction, Medtronic scored a regulatory win of its ...

A minimally invasive, coin-sized implantable device was effective in treating overactive bladder (OAB) syndrome, researchers found. In a prospective, single-arm, open-label study funded by the ...

New Investigational Device Aims to Expand Access to Therapy for Patients with Incontinence; Underscores Medtronic's Leadership as Only Company to Offer Neuromodulation Options for Incontinence DUBLIN, ...